185 related articles for article (PubMed ID: 35950601)
1. Bioequivalence and Pharmacokinetic Study of 2 Edoxaban Tablets in Healthy Chinese Subjects.
Liu L; Li X; Liu Y; Xu B; Li Y; Yuan F; Zhang P; Tu S; Hu W
Clin Pharmacol Drug Dev; 2022 Dec; 11(12):1440-1446. PubMed ID: 35950601
[TBL] [Abstract][Full Text] [Related]
2. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
Chu NN; Zhang L; Wang J; Gu X; Ding Y; Huang K; Que LL; He Q
Clin Drug Investig; 2022 Jan; 42(1):53-63. PubMed ID: 34837169
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
Sun F; Liu Y; Li T; Lin P; Jiang X; Li X; Wang C; Gao X; Ma Y; Fu Y; Cao Y
BMC Pharmacol Toxicol; 2023 Feb; 24(1):7. PubMed ID: 36737825
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Bioequivalence of Two Formulations of Azithromycin Tablets: A Randomized, Single-Dose, Three-Period, Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Chen Y; Ye L; Mei J; Tian M; Xu M; Jin Q; Yu X; Yang S; Wang J
Drugs R D; 2024 May; ():. PubMed ID: 38811485
[TBL] [Abstract][Full Text] [Related]
5. Comparative fasting bioavailability of 2 bepotastine formulations in healthy male Chinese volunteers: an open-label, randomized, single-dose, 2-way crossover study.
Shentu J; Zhou H; Hu X; Wu G; Wu L; Zhu M; Zhai Y; Zheng Y; Liu J
Clin Ther; 2014 Apr; 36(4):579-85. PubMed ID: 24656153
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and bioequivalence studies of fluvoxamine maleate tablets in healthy Chinese subjects.
She DP; He Y; Li MQ; Su L; Ren D; Huang XH; Zhang YH; Hu HT; Deng DC; Wu JL
Biomed Chromatogr; 2023 Jun; 37(6):e5613. PubMed ID: 36849133
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Bioequivalence of 2 Immediate-Release Tofacitinib Tablet Formulations in Chinese Healthy Volunteers Under Fasting and Fed Conditions.
Li X; Liu L; Deng Y; Li Y; Zhang P; Wang Y; Xu B; Feng J; Huang L
Clin Pharmacol Drug Dev; 2021 May; 10(5):535-541. PubMed ID: 32770665
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients with Colorectal or Breast Cancer Under Fed Conditions: A Multicenter, Randomized, Open-Label, Three-Period, and Reference-Replicated Crossover Study.
Wang CJ; Li T; Lin PP; Tao Y; Jiang X; Li X; Wen Q; Cao Y
Adv Ther; 2021 Sep; 38(9):4798-4814. PubMed ID: 34347254
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions.
Li W; Wang Y; Pei Y; Xia Y
Drug Des Devel Ther; 2021; 15():1091-1099. PubMed ID: 33727797
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and bioequivalence evaluation of two different atorvastatin calcium 10-mg tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy fasted Chinese adult males.
Liu YM; Pu HH; Liu GY; Jia JY; Weng LP; Xu RJ; Li GX; Wang W; Zhang MQ; Lu C; Yu C
Clin Ther; 2010 Jul; 32(7):1396-407. PubMed ID: 20678686
[TBL] [Abstract][Full Text] [Related]
11. Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers: an open-label, randomized-sequence, two-period crossover study.
Shi S; Liu Y; Wu J; Li Z; Zhao Y; Zhong D; Zeng F
Clin Ther; 2010 Oct; 32(11):1977-86. PubMed ID: 21095492
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and Bioequivalence of a Generic and a Branded Pazopanib Tablet in Healthy Chinese Subjects.
Liu L; Li X; Liu Y; Li Y; Deng Y; Zhang P; Tu S; Wang K; Xu B
Clin Pharmacol Drug Dev; 2022 Sep; 11(9):1110-1115. PubMed ID: 35384398
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Ornidazole Tablets Bioequivalence in Chinese Healthy Participants Under Fasted and Fed Conditions Using Pharmacokinetic Parameters.
Wang Y; He Y; Li W; Li H; Tang L; Dai X; Pei Y; Gao L
Drugs R D; 2024 Apr; ():. PubMed ID: 38644462
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence of cefalexin in healthy Chinese subjects.
Lv X; Zhong G; Yao H; Wu J; Ye S
Int J Clin Pharmacol Ther; 2021 Nov; 59(11):725-733. PubMed ID: 34448694
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and bioavailability comparison of generic and branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study in healthy Chinese CYP2C19 extensive metabolizers.
Jiang T; Rong Z; Xu Y; Chen B; Xie Y; Chen C; Lu Y; Shen Y; Li H; Sun J; Chen H
Clin Drug Investig; 2013 Jan; 33(1):1-9. PubMed ID: 23179471
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose, randomized, two-way crossover study in healthy Chinese male volunteers.
Liu Y; Jia J; Liu G; Li S; Lu C; Liu Y; Yu C
Clin Ther; 2009 Apr; 31(4):777-83. PubMed ID: 19446150
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, Bioequivalence, and Safety Studies of Pantoprazole Sodium Enteric-Coated Tablets in Healthy Subjects.
Chen Z; Gan F; Rao X; Huang X; Chen H
Clin Pharmacol Drug Dev; 2021 May; 10(5):502-509. PubMed ID: 33128847
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence study of two perindopril tert-butylamine tablet formulations in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial.
Li Q; Hao Z; Yu Y; Tang Y
Biomed Pharmacother; 2021 Mar; 135():111221. PubMed ID: 33433351
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and Bioequivalence of 2 Oral Formulations of Domperidone After Single-Dose Administration in Healthy Chinese Subjects.
Ye L; Shen M; Chen Y; Li X; Xu M; Yao C; Yang S
Clin Pharmacol Drug Dev; 2022 Sep; 11(9):1084-1091. PubMed ID: 35396924
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and Bioequivalence of 2 Nifedipine Controlled-Release Tablets: A Randomized, Single-Dose, 2-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Xin L; Chen Q; Chen D; Li Y; Li Y; Wu Q; Zou Y; Wang W; Jia J; Yu C; Liu Y
Clin Pharmacol Drug Dev; 2023 Nov; 12(11):1082-1088. PubMed ID: 37132398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
